ARIELLE SHETTY: Open Payments
NPI 1790408185 · CUMMING, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,064 in 35 payments from 20 companies in 2025. Trend: 2023 $3,166 · 2024 $3,764 · 2025 $1,064
Food & beverage: $1,064
| Company | Payments | Amount |
|---|---|---|
| SK Life Science, Inc. | 2 | $158 |
| ARGENX US, INC. | 2 | $122 |
| UCB, Inc. | 4 | $115 |
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| Biogen, Inc. | 2 | $62 |
| Novartis Pharmaceuticals Corporation | 2 | $60 |
| ABBVIE INC. | 3 | $56 |
| CATALYST PHARMACEUTICALS, INC. | 2 | $53 |
| Lundbeck LLC | 2 | $50 |
| CSL Behring | 2 | $50 |
Products named: XCOPRI, VYVGART, Rystiggo, KESIMPTA, UBRELVY, REXULTI, FYCOMPA, VYEPTI.
Industry payments across GA — which companies pay providers there.
